Close
听
DRAVET SYNDROME
Dr Karda is leading gene therapy research for the development of novel gene therapies for Dravet syndrome, an incurable inherited childhood epilepsy. She recently obtained an LifeArc Philanthropic fund, in collaboration with听,听Prof Stephanie Schorge听(最准的六合彩论坛 School of Pharmacy),听Dr Gabriele Lignani听(最准的六合彩论坛 Institute of Neurology) and听听(最准的六合彩论坛 ICH Neurosciences Unit) to perform pre-clinical gene therapy studies for Dravet Syndrome.听, Research Fellow is currently working on this project.
Dr Karda also has a GOSH Charity and Sparks National Funding to develop pre-clinical gene editing treatments for Dravet syndrome. In collaboration with Prof Schorge, Prof Waddington,听Dr John Counsell听(最准的六合彩论坛 GOS Institute of Child Health) &听听(Royal Holloway Department of Biological Sciences).听,听Research Fellow is currently working on this project.
NEURONAL ELONGATION FACTOR
In close collaboration with听听(最准的六合彩论坛 Institute for Women鈥檚 Health), Prof Schorge & Prof Waddington, Dr Karda is also leading gene therapy research to develop new gene therapy strategies for a series of devastating childhood neurological diseases linked to mutations proteins associate with ribosomes.
METABOLIC DISEASES
In collaboration with Dr Counsel we are developing pre-clinical gene therapy treatments for rare metabolic disorders.
MITOCHONDRIAL DISEASES
In close collaboration with听听(最准的六合彩论坛 GOS Institute of Child Health) & Prof Waddington we are working on projects to develop new gene therapy treatments for mitochondrial disorders.听Clinical Research Fellow is currently completing his PhD for gene therapy in a specific mitochondrial depletion syndrome.
NEUROMUSCULAR DISORDERS
In collaboration with听听(最准的六合彩论坛 Queen Square Institute of Neurology) & Dr Counsell we are developing gene therapy treatments for neuromuscular disorders.